Oncosteam Biotherapeutics

OncoStem Biotherapeutics is an emerging Bioinformatics and Biotechnology Firm with ownership of a proprietary oncogene database which allows the identification of driver vital oncogenes.

Dr. Willis is a founding member of OncoStem Biotherapeutics. He is a theoretical biologist with over 28 years of experience in all aspects of cancer therapy and research. He is the author of foundational theoretical biology work that serves as the basis for the development of a new class of targeted anti-cancer drugs.

Dr. Willis honorably fulfilled requirements for a combined biology and chemistry B.A. degree at Northwestern University. He earned his M.D. degree at Washington University School of Medicine in St. Louis. He subsequently completed a fellowship at the National Cancer Institute at NIH. There he became a research associate in the Laboratory of Tumor Cell Biology where he earned The Researcher Development Award.

He has served as the Director of the Clinical Trials Subunit at Washington University School of Medicine and participated in innumerable clinical trials. He is the author of several scientific and clinical papers in oncology and molecular biology. He is a member of American Society of Clinical Oncology, American Society for Cell Biology, and a member of the NIH Alumni Association. Currently, he is an Assistant Professor of Medicine at Drexel College of Medicine in Philadelphia, and is earning a MS degree in Bioinformatics from John Hopkins University. He is on the editorial review board of Current Cancer Dug Targets.